Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Cadence Design Systems

Here is a quick recap of two buy-ranked stocks worth buying.

2 Buy-Ranked Stocks with Positive Earnings Surprises & Rising Estimates

Philips (PHG) could produce exceptional returns because of its solid growth attributes.

Philips (PHG) is an Incredible Growth Stock: 3 Reasons Why

Study finds HFCWO Therapy using Philips InCourage System reduces hospitalizations

Koninklijke Philips N.V. (PHG) CEO Frans van Houten on Q2 2020 Results - Earnings Call Transcript

Koninklijke Philips' (PHG) Q2 results reflect the impact of COVID-19 pandemic despite robust performances in the Connected Care businesses.

Koninklijke Philips' (PHG) Q2 Earnings Down on Coronavirus Impact

Philips NV (AMS: PHIA) said that its net profit came in stronger than expected in the second quarter on Monday but saw a significant decline on a year over year basis. The company, however, expressed confidence that profitability is likely to improve in the upcoming months and that it will recover back to sales growth in the remaining two quarters of the financial year.

Philips’ net profit tanks about 15% in the fiscal second quarter

Dutch health technology company Philips has seen a strong rebound in consumer demand in Europe during the second quarter as lockdowns were relaxed, Chief Executive Frans van Houten said on Monday.

Philips CEO sees strong recovery in consumer demand in Europe

Electrical equipment maker Philips said a recent surge in orders for scanners and other medical equipment should enable group sales and margins to rebound over the next six months from a slump in the second quarter.

Surging demand for medical equipment puts Philips on course for second-half recovery

Philips delivers Q2 sales of EUR 4.4 billion, with 6% comparable sales decrease; income from continuing operations of EUR 213 million, Adjusted EBITA margin of 9.5% and operating cash flow of EUR 558 million

Philips appoints Deeptha Khanna as Chief Business Leader of the Personal Health businesses and Edwin Paalvast as Chief of International Markets

Philips and Flevo Hospital sign long-term strategic partnership agreement enabling continuous innovation and optimization of patient care

Philips (PHG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Philips (PHG) Upgraded to Strong Buy: Here's What You Should Know

Philips data-driven Mask Selector delivers unique patient and business benefits

Philips and BioIntelliSense form strategic collaboration to enhance remote patient monitoring for at-risk patients from the hospital into the home

U.S. Department of Veterans Affairs selects Philips to create world’s largest tele-critical care system, further integrating tele-health and delivering quality care for veterans

Amsterdam, the Netherlands and New Delhi, India –  Royal Philips  (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India. Designed to meet the critical-care requirements of patients, each prefabricated ICU has a capacity of nine beds. The units will be locally manufactured by Philips in India, with each ICU unit capable of being deployed in one day.

Philips introduces first-of-a-kind mobile ICUs in India to tackle COVID-19 and other emergencies

Philips announces exchange ratio for 2019 dividend

Philips expands its remote clinical collaboration offering based on the Reacts platform

Philips’ General Meeting of Shareholders approves dividend proposal

New data reconfirms long-term safety profile of the Philips Stellarex low-dose Drug-Coated Balloon

Philips completes cancellation of 3.8 million shares

Philips and Leeds Teaching Hospitals NHS Trust to set new standards for specialist integrated cardiac care

Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart FRx automated external defibrillators

Philips announces collaboration with American Telemedicine Association to further commitment to telehealth

Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers

News for Royal Philips Stock (PHG)